Mozart Therapeutics raises $55M to advance disease therapies

The Seattle company is developing treatments for celiac disease and inflammatory bowel disease.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.